Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesssiRNA-mediated heterochromatin formation

TDRD5 MAEL TDRD12

1.09e-0511853GO:0141194
GeneOntologyBiologicalProcesstransposable element silencing by siRNA-mediated heterochromatin formation

TDRD5 MAEL TDRD12

1.09e-0511853GO:0141007
GeneOntologyBiologicalProcesstransposable element silencing by heterochromatin formation

TDRD5 MAEL TDRD12

5.27e-0518853GO:0141005
GeneOntologyBiologicalProcessNLS-bearing protein import into nucleus

IPO5 RGPD2 KPNB1

7.32e-0520853GO:0006607
GeneOntologyBiologicalProcesspiRNA processing

TDRD5 MAEL TDRD12

9.83e-0522853GO:0034587
GeneOntologyBiologicalProcessribosomal protein import into nucleus

IPO5 KPNB1

1.00e-044852GO:0006610
GeneOntologyBiologicalProcessregulatory ncRNA-mediated heterochromatin formation

TDRD5 MAEL TDRD12

1.13e-0423853GO:0031048
GeneOntologyBiologicalProcessnegative regulation of Ras protein signal transduction

RASA2 RASA4 RASA4B

2.05e-0428853GO:0046580
GeneOntologyBiologicalProcessprotein-DNA complex organization

KNTC1 TDRD5 RUVBL1 RBM15B NSD1 MAEL CHD3 CHD7 LMNB2 GNAS ZZEF1 NSD3 TDRD12

2.16e-049998513GO:0071824
GeneOntologyBiologicalProcesschromatin remodeling

TDRD5 RUVBL1 RBM15B NSD1 MAEL CHD3 CHD7 LMNB2 GNAS NSD3 TDRD12

2.27e-047418511GO:0006338
GeneOntologyBiologicalProcessRNA localization

RGPD2 RUVBL1 RBM15B CCT7 BICD1 KPNB1

2.77e-04217856GO:0006403
GeneOntologyBiologicalProcesschromatin organization

TDRD5 RUVBL1 RBM15B NSD1 MAEL CHD3 CHD7 LMNB2 GNAS ZZEF1 NSD3 TDRD12

2.98e-048968512GO:0006325
GeneOntologyCellularComponentmulti-eIF complex

EIF1AX EIF1AY

9.98e-054862GO:0043614
MousePhenoabnormal blastocyst formation

RGPD2 POLR1A RUVBL1 EIF5B

2.41e-0539614MP:0012128
Domain-

PHLDB3 RGPD2 PHLDB1 GRK3 RASA2 KALRN RASA4 MCF2L2 RASA4B PLEKHA5 PPP4R3A

1.39e-0639184112.30.29.30
DomainPH_dom-like

PHLDB3 RGPD2 PHLDB1 GRK3 RASA2 KALRN RASA4 MCF2L2 RASA4B PLEKHA5 PPP4R3A

3.18e-064268411IPR011993
DomainPH

PHLDB3 PHLDB1 GRK3 RASA2 KALRN RASA4 MCF2L2 RASA4B PLEKHA5

4.37e-06278849SM00233
DomainPH_DOMAIN

PHLDB3 PHLDB1 GRK3 RASA2 KALRN RASA4 MCF2L2 RASA4B PLEKHA5

4.50e-06279849PS50003
DomainPH_domain

PHLDB3 PHLDB1 GRK3 RASA2 KALRN RASA4 MCF2L2 RASA4B PLEKHA5

4.64e-06280849IPR001849
DomainBTK

RASA2 RASA4 RASA4B

7.23e-069843SM00107
DomainZnf_Btk_motif

RASA2 RASA4 RASA4B

7.23e-069843IPR001562
DomainBTK

RASA2 RASA4 RASA4B

7.23e-069843PF00779
DomainZF_BTK

RASA2 RASA4 RASA4B

7.23e-069843PS51113
DomainPH

PHLDB3 PHLDB1 GRK3 RASA2 KALRN RASA4 RASA4B PLEKHA5

8.84e-06229848PF00169
DomainTIF_eIF-1A_CS

EIF1AX EIF1AY

2.00e-052842IPR018104
DomainRasGAP

RASA2 RASA4 RASA4B

3.08e-0514843SM00323
DomainTUDOR

TDRD5 TDRD15 TDRD12

3.08e-0514843PF00567
DomainRasGAP_CS

RASA2 RASA4 RASA4B

3.08e-0514843IPR023152
DomainRasGAP

RASA2 RASA4 RASA4B

3.84e-0515843PF00616
DomainRAS_GTPASE_ACTIV_1

RASA2 RASA4 RASA4B

3.84e-0515843PS00509
DomainRAS_GTPASE_ACTIV_2

RASA2 RASA4 RASA4B

3.84e-0515843PS50018
Domain-

RASA2 RASA4 RASA4B

4.71e-05168431.10.506.10
Domain-

RASA4 RASA4B

5.98e-0538424.10.1130.10
DomainTIF_eIF-1A

EIF1AX EIF1AY

5.98e-053842PD005579
DomainIF1A

EIF1AX EIF1AY

5.98e-053842PS01262
DomainRasGAP_dom

RASA2 RASA4 RASA4B

6.82e-0518843IPR001936
DomainS1_IF1_TYPE

EIF1AX EIF1AY

1.19e-044842PS50832
DomaineIF1a

EIF1AX EIF1AY

1.19e-044842SM00652
DomainRNA-binding_domain_S1_IF1

EIF1AX EIF1AY

1.19e-044842IPR006196
DomaineIF-1a

EIF1AX EIF1AY

1.19e-044842PF01176
DomainTIF_eIF-1A

EIF1AX EIF1AY

1.19e-044842IPR001253
DomainTUDOR

TDRD5 TDRD15 TDRD12

1.46e-0423843PS50304
DomainAWS

NSD1 NSD3

1.98e-045842SM00570
DomainAWS

NSD1 NSD3

1.98e-045842PS51215
DomainAWS_dom

NSD1 NSD3

1.98e-045842IPR006560
DomainTudor

TDRD5 TDRD15 TDRD12

3.26e-0430843IPR002999
DomainATP-grasp

ACACA SUCLG2

1.76e-0314842IPR011761
DomainIMPORTIN_B_NT

IPO5 KPNB1

1.76e-0314842PS50166
DomainATP_GRASP

ACACA SUCLG2

1.76e-0314842PS50975
Domain-

ACACA SUCLG2

2.02e-03158423.30.1490.20
DomainPost-SET_dom

NSD1 NSD3

2.30e-0316842IPR003616
DomainPostSET

NSD1 NSD3

2.30e-0316842SM00508
DomainPOST_SET

NSD1 NSD3

2.30e-0316842PS50868
DomainImportin-beta_N

IPO5 KPNB1

2.60e-0317842IPR001494
DomainATP_grasp_subdomain_1

ACACA SUCLG2

2.92e-0318842IPR013815
Domain-

ACACA SUCLG2

2.92e-03188423.30.470.20
DomainZinc_finger_PHD-type_CS

NSD1 CHD3 NSD3

3.14e-0365843IPR019786
DomainPWWP

NSD1 NSD3

3.60e-0320842SM00293
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

PHLDB3 PHLDB1 POLR1A ADSS2 RUVBL1 ACACA RASA2 MAGED2 UBE3A P4HB PSMA3 EIF5B PLEKHA5 CCT7 NOL10 CHD7 LMNB2 PRPF38A SUCLG2 AQR KPNB1

1.37e-111353872129467282
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

IPO5 KNTC1 POLR1A ADSS2 RUVBL1 ACACA MLEC MAGED2 P4HB PSMA3 NEMF RBM15B EIF5B CCT7 NOL10 LMNB2 GNAS AQR KPNB1

1.89e-091425871930948266
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

IPO5 POLR1A ACACA P4HB ANXA11 USP24 NSD1 EIF5B NOL10 CHD7 LMNB2 AQR KPNB1

9.18e-09653871322586326
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

IPO5 HSPA12A RUVBL1 MAGED2 ANXA11 USP24 CCT7 CHD3 CHD7 GNAS AQR KPNB1

2.44e-08582871220467437
Pubmed

Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.

AMPD1 ATP6V1C1 ADSS2 RUVBL1 ACACA MAGED2 PTGR1 P4HB EIF1AX PSMA3 ANXA11 EIF5B CCT7 GNAS SUCLG2 MMUT KPNB1

4.23e-081367871732687490
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

IPO5 RUVBL1 ACACA MAGED2 P4HB PSMA3 USP24 EIF5B CCT7 LMNB2 PPP4R3A KPNB1

6.64e-08638871233239621
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

RUVBL1 MAGED2 P4HB RBM15B EIF5B PLEKHA5 CCT7 NOL10 LMNB2 GNAS ITGA4 SQOR ITIH2 AQR NSD3 KPNB1

8.16e-081257871636526897
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

IPO5 KNTC1 ATP6V1C1 ADSS2 RUVBL1 ACACA MAGED2 UBE3A P4HB EIF1AX PSMA3 USP24 EIF5B CCT7 ZZEF1 PPP4R3A KPNB1

1.03e-071455871722863883
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

ATP6V1C1 POLR1A MLEC P4HB EIF1AX VPS45 RBM15B NSD1 EIF5B CCT7 NOL10 CHD7 PRPF38A SQOR AQR GGCX NSD3

1.55e-071497871731527615
Pubmed

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.

HSPA12A POLR1A RUVBL1 NSD1 EIF5B CHD3 LMNB2 KPNB1

2.28e-0725087833536335
Pubmed

Inhibition of nuclear import by the proapoptotic protein CC3.

IPO5 HTATIP2 KPNB1

3.01e-07687315282309
Pubmed

C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.

IPO5 RGPD2 POLR1A RUVBL1 ACACA MLEC MAGED2 UBE3A P4HB PSMA3 BAG4 CCT7 GNAS GGCX KPNB1

4.95e-071257871537317656
Pubmed

EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.

IPO5 RUVBL1 MAGED2 P4HB CEP162 NEMF CCT7 LMNB2 GNAS SUCLG2 SQOR KPNB1

7.69e-07803871236517590
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

IPO5 P4HB PCDHGA9 EIF1AX ANXA11 BAG4 RBM15B EIF5B NOL10 PRPF38A AQR KPNB1

8.10e-07807871222681889
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

IPO5 ADSS2 RUVBL1 ACACA MLEC P4HB PSMA3 EIF5B CCT7 GNAS ZZEF1 KPNB1

8.10e-07807871230575818
Pubmed

HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection.

IPO5 LMNB2 KPNB1

8.39e-0788739436978
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

IPO5 POLR1A ADSS2 PTGR1 UBE3A PSMA3 EIF5B CCT7 CHD3 LMNB2 AQR PPP4R3A NSD3

1.42e-061014871332416067
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

RUVBL1 MAGED2 P4HB PSMA3 NEMF RBM15B CHD3 NOL10 CHD7 PRPF38A GNAS SUCLG2 SQOR ITIH2 GGCX

1.46e-061371871536244648
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

IPO5 PHLDB1 POLR1A RUVBL1 P4HB ANXA11 EIF5B CCT7 CHD3 LMNB2 GNAS AQR KPNB1

1.58e-061024871324711643
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

RUVBL1 KALRN P4HB EIF1AX NEMF RBM15B EIF5B CHD7 LMNB2 PRPF38A AQR NSD3 KPNB1

2.89e-061082871338697112
Pubmed

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

IPO5 ACACA MLEC GVINP1 P4HB PSMA3 USP46 GNAS SLC39A10 SQOR CSGALNACT1 NFU1 GGCX PPP4R3A KPNB1

2.93e-061451871530550785
Pubmed

Proteomic analysis of HIV-1 Gag interacting partners using proximity-dependent biotinylation.

ACACA HTATIP2 EIF5B CHD3

3.80e-064287426362536
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

IPO5 ACACA MLEC P4HB DNAJA4 NEMF USP24 EIF5B CCT7 GNAS AQR RABGGTB NSD3 KPNB1

3.99e-061297871433545068
Pubmed

Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.

IPO5 ADSS2 RUVBL1 P4HB PSMA3 CCT7 LMNB2 PPP4R3A KPNB1

4.28e-0649587928581483
Pubmed

eIF1A/eIF5B interaction network and its functions in translation initiation complex assembly and remodeling.

EIF1AX EIF5B

6.19e-06287227325746
Pubmed

Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria.

KALRN CHD7

6.19e-06287228152519
Pubmed

CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.

RASA4 RASA4B

6.19e-06287211448776
Pubmed

Remarkable conservation of translation initiation factors: IF1/eIF1A and IF2/eIF5B are universally distributed phylogenetic markers.

EIF1AX EIF5B

6.19e-06287211699879
Pubmed

eIF5B and eIF1A reorient initiator tRNA to allow ribosomal subunit joining.

EIF1AX EIF5B

6.19e-06287235732735
Pubmed

MAGED2 Is Required under Hypoxia for cAMP Signaling by Inhibiting MDM2-Dependent Endocytosis of G-Alpha-S.

MAGED2 GNAS

6.19e-06287236010623
Pubmed

Linoleic acid improves PIEZO2 dysfunction in a mouse model of Angelman Syndrome.

PIEZO2 UBE3A

6.19e-06287236859399
Pubmed

An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis.

RASA4 RASA4B

6.19e-06287216041389
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

IPO5 POLR1A RUVBL1 MAGED2 CHD3 NOL10 CHD7 NSD3

6.77e-0639487827248496
Pubmed

Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.

RUVBL1 NUAK1 MAGED2 P4HB PSMA3 CCT7 GNAS KPNB1

7.69e-0640187825852190
Pubmed

Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.

KNTC1 POLR1A RUVBL1 MAGED2 PSMA3 ANXA11 CCT7 CHD3 SUCLG2 PPP4R3A KPNB1

8.71e-06847871135235311
Pubmed

Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.

IPO5 RUVBL1 UBE3A FCN2 SQOR KPNB1

9.96e-0619587617110338
Pubmed

CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.

IPO5 MAGED2 P4HB PSMA3 EIF5B CCT7 GNAS KPNB1

1.04e-0541887835338135
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

IPO5 RUVBL1 ACACA P4HB DNAJA4 EIF1AX PSMA3 NEMF USP24 EIF5B CCT7 AQR RABGGTB KPNB1

1.07e-051415871428515276
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

PHLDB3 HSPA12A PHLDB1 ACACA PLEKHA5 USP46 ITGA4 SLC39A10

1.09e-0542187836976175
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

IPO5 ADSS2 RUVBL1 MLEC MAGED2 USP24 EIF5B PLEKHA5 CCT7 KPNB1

1.12e-05708871039231216
Pubmed

Exp5 exports eEF1A via tRNA from nuclei and synergizes with other transport pathways to confine translation to the cytoplasm.

EIF1AX EIF5B EIF1AY

1.20e-051887312426392
Pubmed

SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.

IPO5 ADSS2 MLEC MAGED2 UBE3A P4HB PSMA3 USP24 CCT7 SUCLG2 KPNB1

1.22e-05878871137223481
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

ATP6V1C1 RUVBL1 MAGED2 PSMA3 RBM15B GNAS SQOR

1.41e-0531387738270169
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

IPO5 TARS3 MLEC KALRN UBE3A VPS45 PSMA3 NEMF MCF2L2 CCT7 BRWD3 BICD1 KPNB1

1.82e-051285871335914814
Pubmed

The NSD family of protein methyltransferases in human cancer.

NSD1 NSD3

1.85e-05387225942451
Pubmed

Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules.

IPO5 KPNB1

1.85e-05387212614157
Pubmed

The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties.

IPO5 KPNB1

1.85e-0538729430704
Pubmed

CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane.

RASA4 RASA4B

1.85e-05387225637021
Pubmed

Karyopherins and nuclear import.

IPO5 KPNB1

1.85e-05387211751052
Pubmed

The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.

NSD1 NSD3

1.85e-05387235532818
Pubmed

Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes.

LRRC63 HSPA12A

1.85e-05387217903304
Pubmed

Mapping the binding interface between human eukaryotic initiation factors 1A and 5B: a new interaction between old partners.

EIF1AX EIF5B

1.85e-05387212569173
Pubmed

Nuclear targeting of proteins: how many different signals?

IPO5 KPNB1

1.85e-05387210822175
Pubmed

The interaction between eukaryotic initiation factor 1A and eIF5 retains eIF1 within scanning preinitiation complexes.

EIF1AX EIF1AY

1.85e-05387224319994
Pubmed

Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation.

EIF1AX SUCLG2 EIF1AY

2.25e-052287330951662
Pubmed

LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF-κB to the nucleus.

ACACA ANXA11 EIF5B SQOR

2.34e-056687436398858
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

ACACA MAGED2 PSMA3 USP24 RBM15B EIF5B CHD3 CHD7 PRPF38A PPP4R3A

2.40e-05774871015302935
Pubmed

Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2.

MLEC UBE3A LMNB2 GNAS BICD1

2.69e-0513987525476789
Pubmed

A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.

RUVBL1 MLEC MAGED2 P4HB EIF1AX RALYL CCT7 LMNB2 PRPF38A KPNB1

2.74e-05786871029128334
Pubmed

The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer.

MAGED2 PSMA3 EIF5B KPNB1

3.12e-057187429346117
Pubmed

Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.

IPO5 ACACA CCT7 KPNB1

3.30e-057287436376293
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

IPO5 RUVBL1 P4HB DNAJA4 EIF5B CCT7 SLC39A10 KPNB1

3.43e-0549487826831064
Pubmed

Testicular expression of TDRD1, TDRD5, TDRD9 and TDRD12 in azoospermia.

TDRD5 TDRD12

3.70e-05487232059713
Pubmed

Multiple importins function as nuclear transport receptors for the Rev protein of human immunodeficiency virus type 1.

IPO5 KPNB1

3.70e-05487216704975
Pubmed

Ca2+-dependent monomer and dimer formation switches CAPRI Protein between Ras GTPase-activating protein (GAP) and RapGAP activities.

RASA4 RASA4B

3.70e-05487221460216
Pubmed

The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals.

IPO5 KPNB1

3.70e-0548729891055
Pubmed

Domains of eIF1A that mediate binding to eIF2, eIF3 and eIF5B and promote ternary complex recruitment in vivo.

EIF1AX EIF5B

3.70e-05487212514125
Pubmed

Subcellular distribution of importins correlates with germ cell maturation.

IPO5 KPNB1

3.70e-05487217654710
Pubmed

The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors.

IPO5 KPNB1

3.70e-05487215507604
Pubmed

Human eIF5 and eIF1A Compete for Binding to eIF5B.

EIF1AX EIF5B

3.70e-05487230211544
Pubmed

Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding.

RASA4 RASA4B

3.70e-05487216234249
Pubmed

Histone and DNA binding ability studies of the NSD subfamily of PWWP domains.

NSD1 NSD3

3.70e-05487234271259
Pubmed

FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy.

ATP6V1C1 P4HB PSMA3 LMNB2 SUCLG2 KPNB1

3.86e-0524887632963011
Pubmed

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

RUVBL1 ACACA MAGED2 EIF5B CHD3 CARNMT1 LMNB2 GNAS PPP4R3A

3.92e-0565587935819319
Pubmed

Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.

IPO5 RUVBL1 PSMA3 CCT7 PPP4R3A KPNB1 EIF1AY

4.62e-0537787725147182
Pubmed

Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

TDRD5 TDRD15 RGPD2 MLEC MAGED2 P4HB BAG4 CCT7 CHD3 KPNB1

4.98e-05844871025963833
Pubmed

Proteomic analysis identifies novel binding partners of BAP1.

RUVBL1 MAGED2 GNAS KPNB1

5.00e-058087434591877
Pubmed

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.

RUVBL1 TXNL4B NSD1 EIF5B CHD3 NOL10 NSD3 KPNB1

5.84e-0553387830554943
Pubmed

The importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone H1.

IPO5 KPNB1

6.16e-05587210228156
Pubmed

In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.

NSD1 NSD3

6.16e-05587225494638
Pubmed

Multiple pathways contribute to nuclear import of core histones.

IPO5 KPNB1

6.16e-05587211493596
Pubmed

Systematic perturbations of SETD2, NSD1, NSD2, NSD3, and ASH1L reveal their distinct contributions to H3K36 methylation.

NSD1 NSD3

6.16e-05587239390582
Pubmed

Recognition Elements in the Histone H3 and H4 Tails for Seven Different Importins.

IPO5 KPNB1

6.16e-05587227528606
Pubmed

Intranuclear binding by the HIV-1 regulatory protein VPR is dependent on cytosolic factors.

IPO5 KPNB1

6.16e-05587210772949
Pubmed

Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 Mutations.

MAGED2 GNAS

6.16e-05587227120771
Pubmed

Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways.

IPO5 KPNB1

6.16e-0558729817747
Pubmed

Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.

IPO5 KPNB1

6.16e-0558729621063
Pubmed

Interactions between HIV Rev and nuclear import and export factors: the Rev nuclear localisation signal mediates specific binding to human importin-beta.

IPO5 KPNB1

6.16e-0558729405152
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

HSPA12A P4HB CEP162 CCT7 NOL10 USP46 PRPF38A SLC39A10 PPP4R3A NSD3 KPNB1

6.16e-051049871127880917
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

IPO5 ADSS2 RUVBL1 ACACA P4HB NEMF EIF5B CCT7 GNAS NFU1 AQR KPNB1

6.36e-051247871227684187
Pubmed

The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.

IPO5 RUVBL1 MAGED2 BAG4 NEMF PLEKHA5 GNAS KPNB1

7.00e-0554787837267103
Pubmed

Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.

HSPA12A RUVBL1 P4HB EIF1AX EIF5B CCT7 GNAS KPNB1

8.03e-0555887835063084
Pubmed

Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.

AMPD1 RUVBL1 P4HB BAG4 EIF5B CCT7 GGCX KPNB1 EIF1AY

8.53e-0572587927025967
Pubmed

Comprehensive Target Screening and Cellular Profiling of the Cancer-Active Compound b-AP15 Indicate Abrogation of Protein Homeostasis and Organelle Dysfunction as the Primary Mechanism of Action.

MAGED2 UBE3A PSMA3 CCT7

8.63e-059287435530310
Pubmed

MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.

RUVBL1 PSMA3 ANXA11 CCT7 GNAS ITGA4 ITIH2 KPNB1

8.76e-0556587820458337
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

RGPD2 ACACA USP24 PLEKHA5 CHD3 CHD7 EIF1AY

8.81e-0541887734709266
Pubmed

In-depth protein profiling of the postsynaptic density from mouse hippocampus using data-independent acquisition proteomics.

TDRD5 EIF1AX EIF5B EIF1AY

9.00e-059387425211037
Pubmed

Genetic variation associated with circulating monocyte count in the eMERGE Network.

PTGR1 ITGA4

9.22e-05687223314186
Pubmed

Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage.

AMPD1 ADSS2

9.22e-05687229079593
Pubmed

Structural basis for the nuclear export activity of Importin13.

EIF1AX EIF1AY

9.22e-05687223435562
InteractionSLFN11 interactions

HSPA12A POLR1A RUVBL1 ACACA NSD1 EIF5B CCT7 CHD3 LMNB2 KPNB1

4.56e-063768610int:SLFN11
InteractionCIT interactions

IPO5 POLR1A RUVBL1 MAGED2 KALRN P4HB RALYL EIF5B CHD3 NOL10 LMNB2 PRPF38A GNAS ITGA4 ZZEF1 SQOR AQR BICD1 KPNB1

8.92e-0614508619int:CIT
InteractionMCM2 interactions

TDRD5 TDRD15 RGPD2 RUVBL1 ACACA MLEC NUAK1 MAGED2 UBE3A P4HB BAG4 CCT7 CHD3 ITGA4 PPP4R3A KPNB1

1.17e-0510818616int:MCM2
InteractionSIRT7 interactions

IPO5 POLR1A ACACA P4HB ANXA11 USP24 NSD1 EIF5B NOL10 CHD7 LMNB2 AQR KPNB1

1.54e-057448613int:SIRT7
InteractionKIF23 interactions

IPO5 RUVBL1 NUAK1 MAGED2 CDKL2 P4HB RALYL NSD1 EIF5B CHD3 NOL10 LMNB2 PRPF38A GNAS KPNB1

2.79e-0510318615int:KIF23
InteractionAGR2 interactions

IPO5 ADSS2 RUVBL1 ACACA MLEC PTGR1 P4HB PSMA3 NSD1 EIF5B CCT7 GNAS ZZEF1 KPNB1

3.86e-059348614int:AGR2
InteractionBIRC3 interactions

IPO5 KNTC1 POLR1A ADSS2 RUVBL1 MLEC MAGED2 P4HB PSMA3 RBM15B EIF5B CCT7 NOL10 LMNB2 GNAS AQR KPNB1

4.11e-0513348617int:BIRC3
Cytoband8p11.23

BAG4 ADGRA2

2.31e-04128728p11.23
GeneFamilyPleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing

RASA2 RASA4 RASA4B

3.15e-0610553830
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

PHLDB3 PHLDB1 GRK3 RASA2 RASA4B PLEKHA5

3.70e-05206556682
GeneFamilyTudor domain containing

TDRD5 TDRD15 TDRD12

1.92e-0437553780
GeneFamilyDNA helicases

RUVBL1 CHD7

1.20e-03175521167
GeneFamilyArmadillo repeat containing|Importins

IPO5 KPNB1

1.35e-0318552596
GeneFamilyPWWP domain containing

NSD1 NSD3

2.02e-03225521147
GeneFamilyPHD finger proteins

NSD1 CHD3 NSD3

2.60e-039055388
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

NSD1 NSD3

4.79e-0334552487
CoexpressionGSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN

ADSS2 RUVBL1 ACACA PTGR1 CCT7 SUCLG2 RABGGTB

4.73e-06200877M4885
CoexpressionERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP

UBE3A EIF1AX PSMA3 BAG4 NEMF ITGA4 SLC39A10 SUCLG2 NFU1 RABGGTB EIF1AY

1.70e-056878711M41022
CoexpressionCAIRO_HEPATOBLASTOMA_CLASSES_UP

IPO5 KNTC1 RUVBL1 P4HB USP24 EIF5B CCT7 CHD7 RABGGTB KPNB1

3.56e-056128710M4772
CoexpressionLEE_BMP2_TARGETS_DN

POLR1A RUVBL1 MLEC DNAJA4 EIF1AX USP24 CCT7 NOL10 CARNMT1 USP46 LMNB2 KPNB1

4.34e-059048712M2325
CoexpressionGSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN

GRK3 CCT7 LMNB2 ZZEF1 AQR NSD3

5.09e-05197876M6152
CoexpressionLEE_BMP2_TARGETS_DN

POLR1A RUVBL1 MLEC DNAJA4 USP24 CCT7 NOL10 CARNMT1 USP46 LMNB2 KPNB1 EIF1AY

5.24e-059228712MM1068
CoexpressionGSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN

HSPA12A PTGR1 EIF1AX RBM15B CHD7 CARNMT1

5.53e-05200876M6425
CoexpressionGSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN

NSD1 ITGA4 SUCLG2 SQOR BRWD3 GGCX

5.53e-05200876M6299
CoexpressionGSE27786_BCELL_VS_MONO_MAC_UP

RUVBL1 UBE3A PSMA3 CCT7 ZZEF1 CSGALNACT1

5.53e-05200876M4817
ToppCellfacs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHLDB3 AP4E1 COL6A6 USP24 NOL10 KPNB1

8.17e-07163876132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster

HSPA12A GRK3 NUAK1 CDKL2 RALYL PLEKHA5

2.46e-0619787679b9e7f2e8e33b3c547f716be5667156c48b0dfc
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster

HSPA12A GRK3 NUAK1 CDKL2 RALYL PLEKHA5

2.46e-06197876d20f29088e9afd8a960d6f680075c380e550f8a7
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FBXO40 PIEZO2 KALRN MCF2L2 ADGRA2

1.14e-051508758645b9c7f9511ed6cc9afe04440c2873a3094150
ToppCellEndothelial-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id

PIEZO2 NUAK1 KALRN PCDHGA9 CSGALNACT1

1.81e-0516587510087d8bd2985906ef19547fe77eb178ae5e1638
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO2 NUAK1 KALRN GNAS ADGRA2

2.09e-0517087599dd734c0972a40d5381e8e2d96bdaa31f6d06e6
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO2 NUAK1 KALRN GNAS ADGRA2

2.09e-051708753a14eeae221b8bb0bd0dadcb8e7a603431240a1e
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO2 NUAK1 KALRN GNAS ADGRA2

2.09e-05170875cdb6fad277f284c3fd5a6f45672a8edc24715882
ToppCelldroplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRK3 RASA2 CDKL2 USP24 USP46

2.40e-05175875c1c722db42da9b8a2a46e516ddb83d9be5e2e504
ToppCellCOVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class

GRK3 FCN2 SQOR PPP4R3A NSD3

2.40e-0517587535ea2ed93538e6bf803029fcf7d9243f93e7733d
ToppCellCOVID-19_Severe-Classical_Monocyte-cMono_1|COVID-19_Severe / Disease condition and Cell class

GRK3 FCN2 SQOR PPP4R3A NSD3

2.82e-051818750d07a67e8ee3bca687b378afbc4044434e63556d
ToppCell5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PIEZO2 KALRN TXNL4B ADGRA2 CSGALNACT1

3.21e-0518687540070d9cd20188ba49b32acfca9bc16256b38bf5
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO2 NUAK1 KALRN MCF2L2 ADGRA2

3.30e-0518787515d6e158562d7d85af3ceaf955439b379c8fce81
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO2 NUAK1 KALRN MCF2L2 ADGRA2

3.30e-05187875f62074b631fd45ad299c69d71b09267b04d656ee
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO2 NUAK1 KALRN MCF2L2 ADGRA2

3.38e-0518887532f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCelldroplet-Limb_Muscle-nan-3m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AP4E1 GRK3 KALRN RBM15B ZZEF1

3.47e-0518987516a4c92dd7a0d60f3691bd3130a091a9a54730f1
ToppCellbackground-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells)

PIEZO2 NUAK1 KALRN FCN2 SLC26A5

4.12e-05196875e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

KALRN UBE3A RALYL PLEKHA5 GNAS

4.33e-051988758ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

KNTC1 RGPD2 AMPD1 ITGA4 BICD1

4.43e-051998751bb02f41f3cc76a28581e38b0ca4c36b930b85b4
ToppCellMegakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass

IPO5 RUVBL1 PSMA3 CCT7 KPNB1

4.43e-051998756f159c1215439ec22374903124085746fa8da333
DrugMefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A

IPO5 UBE3A ANXA11 USP24 NSD1 MMUT KPNB1

8.61e-061938676205_DN
Drugleukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA

IPO5 ANXA11 NEMF EIF5B CHD3 LMNB2 RABGGTB

9.21e-061958671108_UP
DrugAlverine citrate salt [5560-59-8]; Down 200; 8.4uM; HL60; HG-U133A

ATP6V1C1 UBE3A NEMF USP46 ZZEF1 RABGGTB BICD1

1.02e-051988671426_DN
DrugCytisine (-) [485-35-8]; Up 200; 21uM; HL60; HG-U133A

ATP6V1C1 MAGED2 CEP162 ITGA4 NSD3 BICD1 KPNB1

1.05e-051998671766_UP
Diseaseuveal melanoma (implicated_via_orthology)

EIF1AX EIF1AY

8.01e-062842DOID:6039 (implicated_via_orthology)
DiseaseSotos syndrome 1 (implicated_via_orthology)

NSD1 NSD3

2.40e-053842DOID:0112103 (implicated_via_orthology)
Diseaseorotate measurement

DNAJA4 TXNL4B

7.96e-055842EFO_0800642
Diseasesleep duration, low density lipoprotein cholesterol measurement

TDRD15 TXNL4B USP24 KPNB1

1.35e-0491844EFO_0004611, EFO_0005271
Diseaseimmature granulocyte measurement

CHD7 ITGA4

1.67e-047842EFO_0803543
Diseaseconcentration of large LDL particles measurement

TDRD15 TXNL4B KPNB1

2.71e-0444843EFO_0022160
Diseasecholesterol in medium VLDL measurement

TDRD15 TXNL4B KPNB1

2.71e-0444843EFO_0022225
Diseasefree cholesterol in very small VLDL measurement

TDRD15 TXNL4B KPNB1

3.30e-0447843EFO_0022275
DiseaseMethylmalonic acidemia

SUCLG2 MMUT

3.55e-0410842C0268583
DiseaseMacrocephaly

CHD3 BRWD3

4.33e-0411842C0221355
DiseaseMethylmalonic aciduria

SUCLG2 MMUT

4.33e-0411842C1855119
Diseasephospholipids in IDL measurement

TDRD15 TXNL4B KPNB1

4.45e-0452843EFO_0022164
Diseasetotal lipids in LDL measurement

TDRD15 TXNL4B KPNB1

4.45e-0452843EFO_0022308
Diseasetotal lipids in large LDL

TDRD15 TXNL4B KPNB1

5.83e-0457843EFO_0022163
Diseasecholesterol in large LDL measurement

TDRD15 TXNL4B KPNB1

5.83e-0457843EFO_0021901
Diseasefree cholesterol measurement, low density lipoprotein cholesterol measurement

TDRD15 TXNL4B USP24 KPNB1

6.44e-04137844EFO_0004611, EFO_0008591
Diseasephospholipids in small LDL measurement

TDRD15 TXNL4B KPNB1

6.45e-0459843EFO_0022297
Diseasetotal lipids in IDL

TDRD15 TXNL4B KPNB1

6.77e-0460843EFO_0022161
Diseaselow density lipoprotein cholesterol measurement, physical activity

TDRD15 TXNL4B KPNB1

8.95e-0466843EFO_0003940, EFO_0004611
Diseasesyndrome (implicated_via_orthology)

NSD1 NSD3

1.19e-0318842DOID:225 (implicated_via_orthology)
Diseasevery low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio

TDRD15 TXNL4B USP24 CSGALNACT1 KPNB1

1.47e-03291845EFO_0008317, EFO_0020946
Diseaseage at menopause

ADSS2 ACACA PTGR1 CHD7 ADGRA2

1.73e-03302845EFO_0004704
Diseaseproprotein convertase subtilisin/kexin type 9 measurement

TDRD15 USP24

1.78e-0322842EFO_0009312
Diseasethalamus volume

NUAK1 PLEKHA5 BICD1

1.86e-0385843EFO_0006935
Diseaseintermediate density lipoprotein measurement

TDRD15 TXNL4B KPNB1

1.99e-0387843EFO_0008595
Diseaselipid measurement, lipoprotein measurement

TDRD15 TXNL4B KPNB1

2.19e-0390843EFO_0004529, EFO_0004732
Diseasehematocrit

AP4E1 TDRD15 ACACA KALRN DNAJA4 TXNL4B CHD3 SLC39A10 TDRD12

2.32e-031011849EFO_0004348
Diseasecholesteryl ester measurement, intermediate density lipoprotein measurement

TDRD15 TXNL4B KPNB1

2.48e-0394843EFO_0008595, EFO_0010351
Diseaselipid measurement, intermediate density lipoprotein measurement

TDRD15 TXNL4B KPNB1

2.63e-0396843EFO_0004529, EFO_0008595

Protein segments in the cluster

PeptideGeneStartEntry
ISKLLGEYEVIFKEQ

TDRD5

316

Q8NAT2
QYLEQEVEEFVGKKT

BAG4

391

O95429
GEFTVEKGLKQIDEY

AKAP14

71

Q86UN6
INEAVPQVKFYEEIK

GRK3

76

P35626
FDIYEIKEAIKGVGT

ANXA11

276

P50995
KIQAAEYGLVVLEEK

BICD1

31

Q96G01
NVVLQYGFKVEVEKE

CARNMT1

366

Q8N4J0
LTVVYFGKEEINEVK

CSGALNACT1

296

Q8TDX6
QKFLGYVDQIKELVE

ADGRA2

471

Q96PE1
FEVLVTEKYEVVKQE

GVINP1

1786

Q7Z2Y8
DVELIYEGVKYVLKV

ACACA

671

Q13085
REQEFVKIVGIKYEV

BRWD3

981

Q6RI45
FDIKVIEDIYEKEIV

AQR

41

O60306
IIKEVGADLVEAKYQ

AMPD1

406

P23109
EGEKFKLISQAYEVL

DNAJA4

41

Q8WW22
YLINGAEEKILEEFK

CHD7

1256

Q9P2D1
KEEYVIVNLVGKIAE

AP4E1

421

Q9UPM8
IINKVFEEKKYVELD

RASA4

371

O43374
VDIEAIFSKYGKIVG

RALYL

36

Q86SE5
AFEKYGIIEEVVIKR

RBM15B

356

Q8NDT2
DIKKGEFVNEYVGEL

NSD1

1961

Q96L73
IINKVFEEKKYVELD

RASA4B

371

C9J798
EGYIIAVKKFLDEIS

RASA2

576

Q15283
KALEDVDYVQTFKGL

PPP4R3A

626

Q6IN85
ETKLKGVIYFQAIEE

PHLDB3

571

Q6NSJ2
EDLVVGIYQQKFLKE

MAEL

246

Q96JY0
YSLEKVFGIQLKEID

MAGED2

326

Q9UNF1
FLYLQVKGEVEAKVE

HTATIP2

141

Q9BUP3
DVIYKGFEDGIVQLK

NFU1

191

Q9UMS0
VDEFYSKIEGQKIDL

NEMF

296

O60524
KLGFYFQSEDIKIEI

ITIH2

761

P19823
KEEGDYVLVLKFAEV

MLEC

116

Q14165
QVLEGEEIAYKFTPK

LMNB2

506

Q03252
LEELEQVVYKPQKFF

DDX58

446

O95786
EEIYIKEIKSIIDGY

MCF2L2

631

Q86YR7
FKVLVEDRVKLYGIE

PCDHGA9

106

Q9Y5G4
EKDYVKDLGIVVEGF

KALRN

1941

O60229
LVFKEDGQEYAQVIK

EIF1AY

26

O14602
AIQFGLDVELVYKVK

KNTC1

416

P50748
YIAVELPKFEESKNI

LRRC63

541

Q05C16
EKLLYKIFGEDFIEQ

HSPA12A

356

O43301
DVFSKYQLDKDGVVL

P4HB

191

P07237
TVLKPQFYEIKAGEE

NOL10

586

Q9BSC4
ELKEGFVEYTEQVVK

IPO5

691

O00410
INVIDVNKVVEYVKG

RABGGTB

111

P53611
ELLVGDVKYGKAVDV

CDKL2

171

Q92772
QVFVLKEGVDYRVKI

ARHGDIG

121

Q99819
KVADEAEKYNLVLGA

FCN2

211

Q15485
FKVAQYVVREEDKIE

CHD3

1286

Q12873
DQIAYVTGEKLYEIK

CEP162

831

Q5TB80
ALAIGGEFKKYLEVV

KPNB1

721

Q14974
ERDFVYGKLEAQEVK

FBXO40

331

Q9UH90
EQIGKAYIFSIDEKE

ITGA4

276

P13612
NKFLEEYDAVLKGLV

SLC39A10

486

Q9ULF5
GDVKETYKVIFVAQV

CFAP74

1566

Q9C0B2
VIKYKEGAVDDIFVE

COL6A6

206

A6NMZ7
DEKVAYLQKLGFDVV

PTGR1

176

Q14914
VLEGKIQYKEYIIEG

PTGR1

291

Q14914
LAQYNFILVVGEKEK

TARS3

746

A2RTX5
LDAFVEGVVKKVAQY

ATP6V1C1

61

P21283
IFGVKKYADALQEII

SQOR

236

Q9Y6N5
IEKEIKDVFAVYGIA

POLR1A

1621

O95602
VEEKYVDDKVLVFLV

TDRD15

1596

B5MCY1
EEGEKVLYSQGVKLF

RGPD2

1046

P0DJD1
TVEKVEKFGLYGLAE

TDRD12

926

Q587J7
YEEVKEIPGIKIFQI

SLC26A5

526

P58743
LNAIKLEEKGVYVQA

EIF5B

971

O60841
FLDKIDVIKQADYVP

GNAS

821

Q5JWF2
AAEFLKQVKPYVEEG

CCT7

101

Q99832
ISIYEVFENKDKIVI

NUAK1

116

O60285
EIKVGVAYKLDGEII

ADSS2

371

P30520
ELIFKEQIDIFEGIK

SUCLG2

186

Q96I99
QIFIVYFIAGVKKLD

GGCX

206

P38435
LKKQLYVEFEGEQGV

UBE3A

551

Q05086
IIGVEKKEGYVLYDL

PIEZO2

2006

Q9H5I5
VKQVITKEYELFEFR

VPS45

191

Q9NRW7
VVFGVEKLVLSKLYE

PSMA3

46

P25788
IIVEFIKNEDFKYVR

PRPF38A

86

Q8NAV1
TKLKGVIYFQAIEEV

PHLDB1

1296

Q86UU1
KKGEFVNEYVGELID

NSD3

1166

Q9BZ95
KVVNKYIDQGIAELV

RUVBL1

281

Q9Y265
IVEKIDAQAIEEFYG

USP46

331

P62068
KKVALTENYELVGVI

USP24

1946

Q9UPU5
AKDLAVDLIEKYVGQ

ZZEF1

986

O43149
ASIIIGYVVIKFNKD

SLC9C2

131

Q5TAH2
FKTKQDFIDLIEVIY

TXNL4B

106

Q9NX01
IEEKKALEAEKYGFQ

PLEKHA5

316

Q9HAU0
LVFKEDGQEYAQVIK

EIF1AX

26

P47813
IVGVNKYQLEKEDAV

MMUT

486

P22033